2023 Regular Session • Alabama Legislature
SB239
Legislative Summary
Relating to Opioid Addiction Treatment; to repeal the Medication Assisted Treatment of Opioid Use Act of 2019, codified as Sections 20-2-300 through 20-2-302, Code of Alabama 1975, that provide for adoption of rules governing use of buprenorphine in the treatment of opioid addiction and a standing working group to assist in drafting the rules.
Bill History
4/25/2023
Read First Time in House of Origin
Senate
4/25/2023
Introduced and Referred to Senate Healthcare
Senate
4/26/2023
Reported Favorably from Senate Healthcare
Senate
4/26/2023
Reported Out of Committee in House of Origin
Senate
4/27/2023
Read Second Time in House of Origin
Senate
5/3/2023
On Third Reading in House of Origin
Senate
5/3/2023
Read a Third Time and Pass
Senate
5/3/2023
Read a Third Time and Pass
Senate
5/4/2023
Read First Time in Second House
Senate
5/4/2023
Referred to Committee to House Health
House of Representatives
5/10/2023
Reported Favorably from House Health
House of Representatives
5/10/2023
Reported Out of Committee in Second House
House of Representatives
5/11/2023
Read Second Time in Second House
House of Representatives
5/18/2023
On Third Reading in Second House
House of Representatives
5/18/2023
Read a Third Time and Pass
House of Representatives
5/18/2023
Ready to Enroll
House of Representatives
5/18/2023
Enrolled
Senate
5/18/2023
Enacted
Senate
Roll Call Votes
Read a Third Time and Pass
5/18/2023
102
Yea
0
Nay
0
Not Voting
3
Absent
Result: PASSED
Status Information
Current Status
Passed(5/18/2023)
Chamber
Senate
Sine DiePrior Session
Sponsors
Republican: 1
Primary Sponsor
Larry Stutts
Republican